Radetti G, Paganini C, Gentili L, Bernasconi S, Betterle C, Borkenstein M, Cvijovic K, Kadrnka-Lovrencic M, Krzisnik C, Battelino T
Department of Paediatrics, General Hospital of Bolzano, Italy.
Acta Diabetol. 1995 Jun;32(2):121-4. doi: 10.1007/BF00569570.
A total of 1419 children with type 1 diabetes mellitus was investigated in order to assess the true frequency of Hashimoto's thyroiditis (HT), diagnosed by microsomal and/or thyroglobulin autoantibodies, by ultrasound and in many cases also by fine needle biopsy. According to these criteria, 55 cases (3.9%) of HT were identified, a number significantly higher (P < 0.0001) than the distribution reported in the normal paediatric population. No typical antibody pattern was seen prior to the onset of HT, nor was an antibody threshold level found which could have been diagnostic for this disease. Patients with subclinical hypothyroidism were treated with L-thyroxine and were investigated regarding the behaviour of anti-thyroid autoantibodies; however, no significant changes were seen. The data showed a high frequency of HT in diabetic children, and therefore we recommend that children with type 1 diabetes mellitus should be screened for thyroid autoantibodies and those positive should undergo periodic thyroid function testing.
为了评估通过微粒体和/或甲状腺球蛋白自身抗体、超声检查以及在许多情况下还通过细针穿刺活检诊断的桥本甲状腺炎(HT)的真实发病率,对总共1419例1型糖尿病患儿进行了调查。根据这些标准,确诊了55例(3.9%)HT患儿,这一数字显著高于(P < 0.0001)正常儿科人群中报告的发病率。在HT发病前未观察到典型的抗体模式,也未发现可用于诊断该疾病的抗体阈值水平。亚临床甲状腺功能减退症患者接受左甲状腺素治疗,并对其抗甲状腺自身抗体的变化情况进行了调查;然而,未观察到显著变化。数据显示糖尿病患儿中HT的发病率较高,因此我们建议对1型糖尿病患儿进行甲状腺自身抗体筛查,阳性者应定期进行甲状腺功能检测。